Xbox Kinect Training in Men With Prostate Cancer

NCT ID: NCT01762241

Last Updated: 2019-03-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

46 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-02-28

Study Completion Date

2018-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate the effect of 12 weeks systematically training using the Xbox Kinect system.

Outcome measures are made on physical function, quality of life, fatigue and metabolic parameters.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients will be recruited from the outpatient clinic at the urological department, Regionshospitalet Holstebro.

Patients who have been discharged from the outpatient clinic due to biochemical stabile cancer prostate disease will receive a letter with information about the study.

A research assistant will be responsible for randomization and test procedures. A physiotherapist will be responsible for instruction of the participants to the training and the Xbox system.

A student will be responsible for installation and collection of the Xbox system in the participants home.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prostate Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention group

12 weeks systematically home based training 3 times per week one hour at the time using the Xbox Kinect system.

Group Type EXPERIMENTAL

Home based training using the Xbox Kinect system

Intervention Type BEHAVIORAL

Home based training 3 times a week for 12 weeks using the Xbox Kinect system

Control group

No systematically training/standard of care

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Home based training using the Xbox Kinect system

Home based training 3 times a week for 12 weeks using the Xbox Kinect system

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Prostate cancer requiring androgen deprivation therapy
* Androgen deprivation therapy for at least 3 month prior to inclusion
* Cognitive well-functioning in order to be able to answer questionnaires and train according to instructions
* Signed informed consent

Exclusion Criteria

* Prostate cancer with metastasis to other regions than bones
* Strength- or cardiovascular training 2 times or more per week prior to inclusion
* Haemoglobin percentage less than 6,1 mmol/l
* Any mental or physical condition that makes the patient unfit for participation
* Men in risk of getting an osteoporotic fracture due to long-term treatment with steroids or earlier fractures due to minimal trauma
* Participation in other studies
Minimum Eligible Age

40 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospitalsenheden Vest

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Brigitta R. Villumsen

PhD stud., Study Nurse, Master of Science in Nursing

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Brigitta R Villumsen, M.S.N.

Role: PRINCIPAL_INVESTIGATOR

Hospitalsenheden Vest

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Urinvejskirurgisk afdeling, Aarhus Universitetshospital, Skejby

Aarhus, , Denmark

Site Status

Regionshospitalet Holstebro, Urinvejskirurgisk afdeling

Holstebro, , Denmark

Site Status

Urologisk afdeling, Regionshospitalet Viborg

Viborg, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1-10-72-593-12

Identifier Type: OTHER

Identifier Source: secondary_id

Wii-1-10-72-593-12

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Transrectal Tumour Oxygen - US Army
NCT00160979 COMPLETED PHASE2